GSK plc Insider Sells Over £1.7 Million in Stock

On February 10th, 2025, insider Emma Walmsley at GSK plc (LON:GSK) sold 120,653 shares of the company. This transaction took place at an average share price of GBX 1,453 ($18.09), culminating in a total sale value of £1,753,088.09 ($2,182,086.25).

GSK Price Performance

As of Thursday, GSK shares opened at GBX 1,445 ($17.99). The company has a market capitalization of £58.96 billion. Its price-to-earnings ratio stands at an extraordinary 1,278.76, while the PEG ratio is reported at 1.24. GSK possesses a beta of 0.31, which indicates lower volatility compared to the market. The 50-day moving average of the stock is priced at GBX 1,363.57, and the 200-day moving average is at GBX 1,455.91. Financially, GSK has a current ratio of 0.82, a quick ratio of 0.73, and a debt-to-equity ratio of 123.04. Over the past year, the stock hit a low of GBX 1,282.50 ($15.96) and a high of GBX 1,823.50 ($22.70).

The last earnings report from GSK was released on February 5th, where the company revealed an earnings per share (EPS) of GBX 23.20 ($0.29) for the quarter. GSK reported a return on equity of 33.30% and a net margin of 12.83%. Analysts are predicting an EPS of 175.981 for the current year.

Analyst Ratings Changes

The stock has been featured in numerous analysis reports recently. Berenberg Bank lowered its price target for GSK from GBX 1,820 ($22.65) to GBX 1,600 ($19.92) but maintained a “buy” recommendation. Meanwhile, JPMorgan Chase & Co. reaffirmed its “underweight” rating in a report dated January 7th. Currently, one analyst recommends selling, another suggests holding, while five analysts advocate buying the shares. According to MarketBeat, GSK currently holds a consensus rating of “Moderate Buy” with a target price of GBX 1,805.83 ($22.48).

About GSK

GSK plc, along with its subsidiaries, is engaged in the research, development, and manufacturing of vaccines, specialty medicines, and general medications to prevent and treat diseases in various markets, including the United Kingdom and the United States.

Read More

• Five stocks we like better than GSK
• What is a Bond Market Holiday? How to Invest and Trade
• 3 Reasons Micron Stock Is Deeply Undervalued Right Now
• Stock Market Sectors: What Are They and How Many Are There?
• Inflation Persists, But So Do Stock Opportunities: Rally On
• Unveiling The Power Of VWAP: A Key Indicator For Traders
• Energy Transfer Fuels the Cloud: A Natural Gas Power Play

GSK, insider, stocks